跳至主要内容
临床试验/CTRI/2023/12/060794
CTRI/2023/12/060794尚未招募3 期

Evaluation of Comparative Efficacy of Kalmegh Vati versus Amlodipine in the Management of Stage 1 Essential Hypertension A Randomized Controlled Trial - NI

Dr Vinay Kumar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients, willing to participate with written informed consent.
  • 2.Age between 30-60 years of either sex.
  • Subjects having Systolic blood pressure 140-159mmHg & Diastolic blood pressure between 90-
  • 99mmHg (Stage-1 hypertension as per JNC 8 guidelines).

排除标准

  • 1.Cases of major illness like cardiovascular disorders like cardiogenic shock, unstable angina,
  • aortic stenosis, diabetes mellitus and renal disorders.
  • 2.Patients taking medication like glucocorticoids.
  • 3.Pregnant and lactating women.

研究者

发起方
Dr Vinay Kumar

相似试验